{"id":16937,"date":"2021-03-19T12:39:49","date_gmt":"2021-03-19T11:39:49","guid":{"rendered":"https:\/\/idibell.cat\/?p=16937"},"modified":"2021-03-19T12:40:15","modified_gmt":"2021-03-19T11:40:15","slug":"la-deteccio-precoc-del-deteriorament-dels-pacients-covid-19-per-part-del-personal-dinfermeria-en-millora-la-recuperacio","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/03\/la-deteccio-precoc-del-deteriorament-dels-pacients-covid-19-per-part-del-personal-dinfermeria-en-millora-la-recuperacio\/","title":{"rendered":"La detecci\u00f3 preco\u00e7 del deteriorament dels pacients COVID-19 per part del personal d\u2019infermeria en millora la recuperaci\u00f3"},"content":{"rendered":"<p>El <strong>sistema de Vigil\u00e0ncia i identificaci\u00f3 del deteriorament agut<\/strong> (VIDA) cont\u00e9 un algoritme adaptat de manera local a cada hospital de l\u2019Institut Catal\u00e0 de la Salut (ICS). Aquest projecte, desenvolupat i liderat per <strong>Maria Eul\u00e0lia Juv\u00e9<\/strong> cap de grup de l\u2019IDIBELL i adjunta d\u2019hospitals a la Direcci\u00f3 de Cures de l\u2019ICS, identifica de forma preco\u00e7 el risc de deteriorament agut mitjan\u00e7ant un sistema de puntuaci\u00f3 i un algoritme de decisi\u00f3 resultants del monitoratge del pacient. Aquest sistema es va implementar per primera vegada el 2013 i, actualment, s\u2019utilitza di\u00e0riament per ajudar a la presa de decisions cl\u00edniques en els pacients hospitalitzats als 8 hospitals de l\u2019ICS.<\/p>\n<p>Ara, el Grup de Recerca Infermera (<a href=\"https:\/\/idibell.cat\/recerca\/area-de-medicina-translacional\/programa-de-sistema-digestiu-diagnostic-farmacogenetica-infermeria-i-prevencio-clinica\/enfermeria\/\">GRIN<\/a>) de l\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) ha publicat un estudi a la revista <a href=\"https:\/\/bmjopen.bmj.com\/content\/11\/2\/e041726\">BMJ Open<\/a>. Aquest estudi tenia com a objectiu determinar l\u2019associaci\u00f3 entre el risc de deteriorament agut, els factors de complexitat de cures i els resultats desfavorables en pacients que han ingressat per <strong>COVID-19<\/strong>. Els resultats constaten que amb el sistema de vigil\u00e0ncia \u00e9s possible detectar\u00a0 m\u00e9s r\u00e0pidament complicacions en l\u2019estat de salut dels pacients, cosa que evita d\u2019aquesta manera trasllats a les unitats de cures intensives (UCI) i aconsegueix reduir la mortalitat intrahospital\u00e0ria o d\u2019altres complicacions evitables pel fet que permet actuar-hi de manera m\u00e9s preco\u00e7. Es tracta d\u2019un estudi de cohorts multic\u00e8ntric entre la poblaci\u00f3 adulta ingressada per COVID-19 a set hospitals de Catalunya.<\/p>\n<p>Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), &#8220;<em>els pacients hospitalitzats amb COVID-19 requereixen un control regular de les constants vitals i, quan \u00e9s possible, utilitzar sistemes d\u2019alerta que facilitin el reconeixement preco\u00e7 i permetin intensificar el tractament en el cas de deteriorament del pacient<\/em>.\u201d Aix\u00ed, els sistemes d\u2019alerta preco\u00e7 s\u2019han convertit en un component important de la gesti\u00f3 de l\u2019atenci\u00f3 hospital\u00e0ria i s\u00f3n una bona eina cl\u00ednica d\u2019estratificaci\u00f3 i de suport a la presa de decisions. Com explica <strong>Jordi Adamuz<\/strong> investigador de l\u2019IDIBELL i infermer de l\u2019Hospital de Bellvitge, \u201c<em>l\u2019estudi ha perm\u00e8s demostrar no nom\u00e9s que el sistema VIDA \u00e9s capa\u00e7 de detectar pacients amb m\u00e9s complicacions evitables, sin\u00f3 que tamb\u00e9 contribueix a disminuir la mortalitat intrahospital\u00e0ria<\/em>\u201d.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un estudi constata que m\u00e9s vigil\u00e0ncia infermera sistematitzada mitjan\u00e7ant el sistema VIDA, desenvolupat per l\u2019Institut Catal\u00e0 de la Salut i l\u2019IDIBELL, \u00e9s capa\u00e7 de detectar i prevenir les complicacions evitables, els trasllats a l\u2019UCI i la mortalitat intrahospital\u00e0ria<\/p>\n","protected":false},"author":8,"featured_media":16941,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[476,334,469],"tags":[],"class_list":["post-16937","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infermeria","category-medicina-translacional","category-p-de-sistema-digestiu-diagnostic-farmacogenetica-infermeria-i-prevencio-clinica"],"publishpress_future_action":{"enabled":false,"date":"2024-10-24 23:42:02","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16937"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=16937"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16937\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/16941"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=16937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=16937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=16937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}